LC-MS/MS bioanalytical challenge: ultra-high sensitivity assays

Area of Science:

• Pharmaceutical Science
• Analytical Chemistry
• Biotechnology

Background:

• Bioanalytical assays are crucial for drug development, supporting toxicology and clinical studies.
• Developing ultrasensitive assays (low pg/ml) presents significant practical challenges in regulated environments.
• Existing methods often face difficulties with sample preparation, matrix effects, and assay robustness.

Purpose of the Study:

• To review the challenges associated with developing and running low pg/ml liquid chromatography-tandem mass spectrometry (LC-MS/MS) bioanalytical assays.
• To identify practical solutions for implementing ultrasensitive assays in regulated laboratories.
• To highlight the importance of optimizing sample preparation, chromatographic separation, and mass spectrometric detection.

Main Methods:

• Review of practical problems in implementing ultrasensitive bioanalytical assays.
• Focus on controlling sample losses and contamination.
• Strategies for eliminating matrix interferences and ensuring assay robustness.

Main Results:

• Sensitivity on the instrument is less of a challenge than procedural controls.
• Optimizing sample preparation, chromatography, and detection are critical for assay success.
• Advancements in mass spectrometry instrumentation have enabled lower detection limits.

Conclusions:

• Successful development of ultrasensitive LC-MS/MS bioanalytical assays hinges on optimizing all assay components.
• Robust procedures to minimize contamination and matrix effects are paramount for validation.
• Progress in mass spectrometry technology is vital for achieving low pg/ml bioanalysis in regulated settings.